Protara Therapeutics, Inc. SEC filings TARA
Protara Therapeutics, Inc. has 809 filings in SEC EDGAR's recent list, going back to Apr 14, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 24, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Other events
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 8, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 19, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2025 | Apr 26, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 11, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2024 | Dec 5, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Apr 5, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 2, 2023 | May 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 30, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Other events
|
Jan 5, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 18, 2022 | Jul 16, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 21, 2022 | Jun 20, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2022 | Mar 9, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 18, 2021 | Oct 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2021 | Oct 12, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Jun 10, 2021 | Jun 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 23, 2021 | Apr 23, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 19, 2021 | Apr 19, 2021 |
| 8-K |
Current report
Auditor change
|
Mar 17, 2021 | Mar 12, 2021 |
| 8-K |
Current report
Other events
|
Mar 3, 2021 | Mar 3, 2021 |
| 8-K |
Current report
Other events
|
Feb 11, 2021 | Feb 11, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 2, 2021 | Jan 29, 2021 |
| 8-K |
Current report
Material agreement
|
Dec 8, 2020 | Dec 7, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 7, 2020 | Dec 1, 2020 |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 12, 2020 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Oct 8, 2020 | Jun 9, 2020 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change, Other events
|
Sep 23, 2020 | Sep 21, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 8, 2020 | Sep 8, 2020 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 24, 2020 | Jul 20, 2020 |
| 8-K |
Current report
Material agreement
|
Jul 16, 2020 | Jul 14, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2020 | Jun 9, 2020 |
| 8-K |
Current report
Other events
|
Mar 30, 2020 | Mar 26, 2020 |
| 8-K |
Current report
Auditor change
|
Mar 23, 2020 | Mar 18, 2020 |
| 8-K/A | Amended current report | Mar 20, 2020 | Jan 6, 2020 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 11, 2020 | Feb 6, 2020 |
| 8-K |
Current report
Acquisition or sale of assets, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Jan 10, 2020 | Jan 6, 2020 |
| 8-K |
Current report
Other events
|
Dec 31, 2019 | Dec 31, 2019 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2019 | Dec 20, 2019 |
| 8-K |
Current report
Other events
|
Nov 21, 2019 | Nov 15, 2019 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2019 | Oct 31, 2019 |
| 8-K |
Current report
Listing notice
|
Oct 10, 2019 | Oct 7, 2019 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Other events
|
Sep 24, 2019 | Sep 24, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change
|
Sep 24, 2019 | Sep 22, 2019 |
| 8-K |
Current report
Other events
|
Sep 23, 2019 | Sep 23, 2019 |
| 8-K |
Current report
Listing notice
|
Aug 15, 2019 | Aug 12, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2019 | Aug 7, 2019 |
| 8-K |
Current report
Listing notice
|
May 15, 2019 | May 10, 2019 |
| 8-K |
Current report
Results of operations
|
May 8, 2019 | May 8, 2019 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 15, 2019 | Apr 15, 2019 |
| 8-K |
Current report
Other events
|
Mar 28, 2019 | Mar 28, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2019 | Mar 13, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2018 | Nov 7, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2018 | Aug 7, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2018 | Jun 8, 2018 |
| 8-K |
Current report
Results of operations
|
May 9, 2018 | May 9, 2018 |
| 8-K |
Current report
Material agreement, Other events
|
May 8, 2018 | May 4, 2018 |
| 8-K |
Current report
Other events
|
Mar 14, 2018 | Mar 14, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2018 | Mar 14, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2018 | Mar 5, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2017 | Nov 7, 2017 |
| 8-K |
Current report
Material agreement
|
Aug 22, 2017 | Aug 17, 2017 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2017 | Aug 7, 2017 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Aug 3, 2017 | Jul 31, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2017 | Jun 20, 2017 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 23, 2017 | Jun 22, 2017 |
| 8-K |
Current report
Other events
|
Jun 22, 2017 | Jun 22, 2017 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 10, 2017 | May 10, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
May 2, 2017 | May 2, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 22, 2017 | Mar 21, 2017 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 16, 2017 | Mar 16, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 13, 2016 | Dec 13, 2016 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2016 | Nov 7, 2016 |
| 8-K |
Current report
Officer or director change
|
Oct 20, 2016 | Oct 18, 2016 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2016 | Aug 8, 2016 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2016 | Jun 9, 2016 |
| 8-K |
Current report
Results of operations
|
May 9, 2016 | May 9, 2016 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2016 | Mar 14, 2016 |
| 8-K |
Current report
Material agreement
|
Jan 22, 2016 | Jan 21, 2016 |
| 8-K |
Current report
Material agreement
|
Nov 12, 2015 | Nov 12, 2015 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2015 | Nov 12, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 2, 2015 | Nov 2, 2015 |
| 8-K |
Current report
Officer or director change
|
Oct 19, 2015 | Oct 16, 2015 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2015 | Aug 13, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 13, 2015 | Aug 13, 2015 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2015 | Jul 21, 2015 |
| 8-K |
Current report
Material agreement
|
Jul 13, 2015 | Jul 9, 2015 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2015 | Jun 2, 2015 |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2015 | Jun 1, 2015 |
| 8-K |
Current report
Results of operations
|
May 13, 2015 | May 13, 2015 |
| 8-K |
Current report
Other events
|
Apr 2, 2015 | Apr 2, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2015 | Mar 26, 2015 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2015 | Mar 20, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 8, 2014 | Dec 8, 2014 |
| 8-K |
Current report
Results of operations
|
Nov 25, 2014 | Nov 25, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 27, 2014 | Oct 27, 2014 |
Showing 130 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TARA (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1359931
- Former names
- Protara Therapeutics, Inc. (until Aug 13, 2026); ArTara Therapeutics, Inc. (until Apr 23, 2020); PROTEON THERAPEUTICS INC (until Dec 31, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.